Barclays’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-881,402
Closed -$78.5M 7220
2017
Q1
$78.5M Buy
881,402
+681,629
+341% +$56.1M 0.19% 173
2016
Q4
$14.1M Buy
199,773
+88,834
+80% +$6.62M 0.04% 776
2016
Q3
$8.76M Sell
110,939
-35,043
-24% -$2.99M 0.03% 940
2016
Q2
$13.2M Sell
145,982
-52,120
-26% -$4.41M 0.04% 702
2016
Q1
$16.6M Buy
198,102
+110,893
+127% +$8.25M 0.06% 546
2015
Q4
$6.8M Sell
87,209
-22,684
-21% -$1.79M 0.02% 1101
2015
Q3
$7.69M Sell
109,893
-24,843
-18% -$2.04M 0.02% 1089
2015
Q2
$12.1M Buy
134,736
+42,585
+46% +$4.11M 0.03% 913
2015
Q1
$9.22M Sell
92,151
-59,930
-39% -$6.04M 0.02% 1124
2014
Q4
$15.2M Buy
152,081
+32,091
+27% +$3.2M 0.03% 912
2014
Q3
$11.5M Sell
119,990
-92,164
-43% -$8.73M 0.02% 1068
2014
Q2
$19.7M Buy
212,154
+105,860
+100% +$9.26M 0.04% 707
2014
Q1
$8.82M Sell
106,294
-77,218
-42% -$6.26M 0.02% 1237
2013
Q4
$15.2M Buy
183,512
+26,303
+17% +$2.14M 0.03% 946
2013
Q3
$11.6M Buy
157,209
+52,371
+50% +$3.93M 0.03% 1036
2013
Q2
$8.31M Buy
+104,838
New +$8.41M 0.02% 1215

Other funds holding MJN